摘要
目的：探讨应用医用臭氧椎间盘内注射治疗颈椎间盘突出症的疗效及影响因素。比较经皮椎间盘臭氧治疗与硬膜外腔给药的疗效。方法：回顾性分析2005年1月至2006年1月间因颈椎间盘突出症住院采用医用三氧椎间盘内注射（188例）与硬膜外腔注药（188例）治疗病例。结果：所有病例随访3～13个月，医用三氧（PCOI）组平均7．18±3．27月，硬膜外腔注药（PEMI）组7．00±3．26月；两组手术临床效果均有显著性差异（P〈0．05）；两组之间亦有显著性差异（P〈0．05）。结论：医用三氧椎间盘内注射及硬膜外腔注药治疗颈椎间盘突出症均具有较高的安全性及较好的疗效，但医用三氧组临床效果明显优于硬膜外腔组。
Objective ： To analyze the influence factors of percutaneous cervical intervertebral disc ozone injection and compare the clinical therapeutic effect of curing cervical intervertebral disc protrusion between percutaneous cervical intervertebral disc ozone injection （PCOI） and percutaneous epidural cavity mixed medicine injection （PEMI）. Methods： Retrospective study of medical ozone injected into intervertebral disc （ n = 188 ） or mixed medicine injection into epidural cavity （ n = 188 ） to cure 376 patients with cervical intervertebral disc protrusion. Results： All cases followed up for 3 months to 13 months, average 7.18 ± 3.27 months on the PCOI group and 7.00 ± 3.26 months on the PEMI group. All cases have been successfully operated. There was no significant difference in the operation time between two groups. There was significant difference between the pre- and post-operation scores of each group. Significant difference was also observed in the clinical outcomes between two groups. Conclusion： While both PCOI and PEMI have high security and good therapeutic in curing cervical intervertebral disc protrusion, PCOI was significantly superior to PEMI.
出处
《中国疼痛医学杂志》
CAS
CSCD
北大核心
2007年第1期24-26,31,共4页
Chinese Journal of Pain Medicine
关键词
经皮椎间盘臭氧注射术
疗效
经皮硬膜外腔注药术
颈椎间盘突出症
Percutaneous cervical intervertebral disc ozone injection （PCOI）
Curative effect
Percutaneous epidural cavity mixed medicine injection （PEMI）
Cervical intervertebral disc protrusion
